Bicocca Open Archive

Logo unimib boa
AROLDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.491
EU - Europa 1.393
AS - Asia 871
SA - Sud America 70
AF - Africa 12
OC - Oceania 1
Totale 3.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.476
IT - Italia 521
SG - Singapore 287
RU - Federazione Russa 260
DE - Germania 198
HK - Hong Kong 189
CN - Cina 136
IE - Irlanda 133
VN - Vietnam 133
SE - Svezia 99
BR - Brasile 55
FR - Francia 32
GB - Regno Unito 31
FI - Finlandia 30
ID - Indonesia 30
KR - Corea 23
IN - India 18
TR - Turchia 16
NL - Olanda 15
ES - Italia 12
UA - Ucraina 11
CA - Canada 10
AT - Austria 9
PL - Polonia 9
AR - Argentina 8
CZ - Repubblica Ceca 8
EG - Egitto 8
PT - Portogallo 8
IR - Iran 6
PK - Pakistan 6
CO - Colombia 5
NO - Norvegia 5
JP - Giappone 4
BG - Bulgaria 3
IL - Israele 3
KG - Kirghizistan 3
MX - Messico 3
AM - Armenia 2
AZ - Azerbaigian 2
CH - Svizzera 2
IQ - Iraq 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PA - Panama 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.838
Salva come PNG Salva come JPEG
Città #
Ann Arbor 545
Hong Kong 183
Singapore 178
Milan 175
Dublin 133
Frankfurt am Main 122
Chandler 86
New York 75
Fairfield 70
Wilmington 68
Woodbridge 62
Santa Clara 53
Ashburn 46
Hanoi 43
Seattle 34
Houston 32
Ho Chi Minh City 31
Shanghai 29
Jakarta 28
Los Angeles 24
Princeton 24
Seoul 22
Cambridge 20
Beijing 19
Lissone 19
Moscow 18
Rome 18
Hefei 17
Monza 17
Munich 16
Helsinki 14
Romola 14
Nuremberg 13
Guangzhou 12
Lawrence 12
Altamura 11
Desio 11
Bologna 10
Chicago 10
Turin 10
Dallas 9
Sesto San Giovanni 9
Como 8
Dong Ket 8
Jacksonville 8
San Diego 8
Tianjin 8
Dearborn 7
Garbsen 7
Lappeenranta 7
London 7
Seregno 7
Turku 7
Boardman 6
Carate Brianza 6
Council Bluffs 6
Düsseldorf 6
Fremont 6
Genoa 6
Lauterbourg 6
Andover 5
Haiphong 5
Olomouc 5
Sargodha 5
São Paulo 5
Assago 4
Bonndorf 4
Cinisello Balsamo 4
Da Nang 4
Falls Church 4
Lisbon 4
Lodz 4
Oslo 4
Pavia 4
Pune 4
Sacramento 4
Tehran 4
Toronto 4
Agrate Brianza 3
Ankara 3
Arese 3
Bari 3
Bergamo 3
Berlin 3
Bishkek 3
Bogotá 3
Buenos Aires 3
Ceret 3
Chengdu 3
Colorado Springs 3
Corbetta 3
Delhi 3
Istanbul 3
Kocaeli 3
Legnano 3
Lleida 3
Nanchang 3
Portsmouth 3
Quận Bình Thạnh 3
Sacavém 3
Totale 2.609
Salva come PNG Salva come JPEG
Nome #
Chronic myeloid leukemia: Second-line drugs of choice 284
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 235
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 225
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 217
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 215
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 213
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 182
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study) 181
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 179
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 179
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 173
Idiopathic erythrocytosis: a germline disease? 155
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies 147
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 136
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 130
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 128
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 127
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 101
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 100
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 94
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 90
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 90
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 70
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 56
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 53
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 47
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 44
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 26
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 25
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options 22
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors 20
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 10
Totale 3.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 0 5
2020/2021663 37 17 66 57 58 75 58 60 69 47 58 61
2021/2022295 52 36 48 38 14 23 4 8 7 10 17 38
2022/2023421 37 117 37 27 24 62 29 8 35 12 26 7
2023/2024650 14 20 30 27 61 175 96 25 67 42 26 67
2024/20251.745 56 141 88 76 119 88 113 69 170 323 213 289
Totale 3.954